Akari Therapeutics Plc Aktien im Umlauf
Was ist das Aktien im Umlauf von Akari Therapeutics Plc?
Aktien im Umlauf von Akari Therapeutics Plc ist 12.145M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Akari Therapeutics Plc
Was macht Akari Therapeutics Plc?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Unternehmen mit aktien im umlauf ähnlich Akari Therapeutics Plc
- Credit Acceptance hat Aktien im Umlauf von 12.111M
- Stratec SE hat Aktien im Umlauf von 12.128M
- Immunome hat Aktien im Umlauf von 12.129M
- Swaraj Engines hat Aktien im Umlauf von 12.134M
- Swaraj Engines hat Aktien im Umlauf von 12.141M
- Le Tanneur & Cie Societe anonyme hat Aktien im Umlauf von 12.144M
- Akari Therapeutics Plc hat Aktien im Umlauf von 12.145M
- S&U Plc hat Aktien im Umlauf von 12.151M
- John Hancock Hedged equity & Income Fund hat Aktien im Umlauf von 12.151M
- Gandhi Special Tubes hat Aktien im Umlauf von 12.152M
- Emmis Corp hat Aktien im Umlauf von 12.157M
- Prime People Plc hat Aktien im Umlauf von 12.157M
- PermRock Royalty Trust hat Aktien im Umlauf von 12.166M